E7386

· Eisai Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for E7386, covering 2025-10-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor [Phase 1, Phase 2]